Latvia Pharmaceuticals and Healthcare Report Q3 2012Business Monitor International
May 8, 2012
80 Pages - SKU: BMI3891560
More Prescription Drugs reports by Business Monitor International
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Sudan will remain one of the least attractive countries in the Middle East/Africa region due tolow pharmaceutical and healthcare expenditure. The government's low ...
Pakistan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Increased longevity in developed markets translates into an increased demand for aged carehealthcare services and medicines. However, in emerging markets such as Pakistan, ...
Japan Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: Japan remains the most attractive market in the Asia Pacific, due to the ageing and affluentpopulation and strong regulatory conditions. In particular, we ...
Croatia Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor InternationalSee all reports like this >>
Executive SummaryBMI View: Croatia's entrance into the EU will accelerate its economic liberalisation and the developmentof the country's private sector. It is also likely to ...
More Latvia Prescription Drugs reports
Latvia Pharmaceuticals and Healthcare Report Q2 2013 by Business Monitor International
BMI View: We view Latvia’s pharmaceutical market as one of the least promising in the EmergingEurope region, from a longer-term point of view. Despite a ...
Antibiotics Market in Latvia to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Latvia. The study provides essential market ...
Latvia Pharmaceuticals and Healthcare Report Q4 2012 by Business Monitor International
BMI View: Despite a downward revision to our overall assessment of the size of Latvia's pharmaceutical market, we remain cautiously optimistic about the development of ...
The Pharmaceutical Market: Latvia by Espicom Healthcare IntelligenceSee all reports like this >>
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
More Latvia reports
D&B Country RiskLine Report: Latvia by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: Latvia by Dun & Bradstreet Inc.See all reports like this >>
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
We can help you find what you need. Call us or write us:
Need help in your search?
- Hospitals & Clinics
- Country Overviews
- Life Sciences
- Country Overviews
- Manufacturing, Packaging & Detailing
- Prescription Drugs
Prescription Drugs Reports